NO20040158L - Fremgangsmåte til å amplifisere et Chordopoxvirus. - Google Patents

Fremgangsmåte til å amplifisere et Chordopoxvirus.

Info

Publication number
NO20040158L
NO20040158L NO20040158A NO20040158A NO20040158L NO 20040158 L NO20040158 L NO 20040158L NO 20040158 A NO20040158 A NO 20040158A NO 20040158 A NO20040158 A NO 20040158A NO 20040158 L NO20040158 L NO 20040158L
Authority
NO
Norway
Prior art keywords
amplifying
chordopox virus
chordopox
virus
Prior art date
Application number
NO20040158A
Other languages
English (en)
Other versions
NO339056B1 (no
Inventor
Paul Howley
Karl Heller
Ingmar Räthe
Original Assignee
Bavarian Nordic As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8160630&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20040158(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bavarian Nordic As filed Critical Bavarian Nordic As
Publication of NO20040158L publication Critical patent/NO20040158L/no
Publication of NO339056B1 publication Critical patent/NO339056B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A61K39/285—Vaccinia virus or variola virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01—DNA viruses
    • C07K14/065—Poxviridae, e.g. avipoxvirus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/01—DNA viruses
    • C07K14/065—Poxviridae, e.g. avipoxvirus
    • C07K14/07—Vaccinia virus; Variola virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24051—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO20040158A 2001-07-18 2004-01-13 Fremgangsmåte til å amplifisere et Chordopoxvirus. NO339056B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200101122 2001-07-18
PCT/EP2002/007280 WO2003008533A2 (en) 2001-07-18 2002-07-02 Method for virus propagation

Publications (2)

Publication Number Publication Date
NO20040158L true NO20040158L (no) 2004-01-13
NO339056B1 NO339056B1 (no) 2016-11-07

Family

ID=8160630

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040158A NO339056B1 (no) 2001-07-18 2004-01-13 Fremgangsmåte til å amplifisere et Chordopoxvirus.

Country Status (20)

Country Link
US (1) US6924137B2 (no)
EP (1) EP1412486B1 (no)
JP (2) JP4700907B2 (no)
KR (1) KR100908377B1 (no)
CN (1) CN100513560C (no)
AU (1) AU2002314201B2 (no)
BR (2) BR0211276A (no)
CA (1) CA2450206C (no)
DE (1) DE60223812T2 (no)
DK (1) DK1412486T3 (no)
EA (1) EA006628B1 (no)
HK (1) HK1066245A1 (no)
HU (1) HUP0400393A3 (no)
IL (2) IL158927A0 (no)
MX (1) MXPA04000326A (no)
NO (1) NO339056B1 (no)
NZ (1) NZ529914A (no)
PL (1) PL205926B1 (no)
UA (1) UA82466C2 (no)
WO (1) WO2003008533A2 (no)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO343489B1 (no) * 2002-09-05 2019-03-25 Bavarian Nordic As Fremgangsmåte til amplifisering av en poxvirus under serumfrie betingelser.

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7445924B2 (en) 2000-11-23 2008-11-04 Bavarian Nordic A/S Modified Vaccinia Ankara virus variant and cultivation method
EE05680B1 (et) * 2000-11-23 2013-10-15 Bavarian Nordic A/S Muundatud vaktsiiniaviirus, selle valmistamine ja kasutamine, seda sisaldav farmatseutiline kompositsioon ning vaktsiin
US8691502B2 (en) 2008-10-31 2014-04-08 Tremrx, Inc. T-cell vaccination with viral vectors via mechanical epidermal disruption
JP6333814B2 (ja) 2012-07-10 2018-05-30 トランジェーヌ、ソシエテ、アノニムＴｒａｎｓｇｅｎｅ Ｓ．Ａ． マイコバクテリア抗原ワクチン
WO2014009433A1 (en) 2012-07-10 2014-01-16 Transgene Sa Mycobacterium resuscitation promoting factor for use as adjuvant
JP6605480B2 (ja) 2014-01-09 2019-11-13 トランスジェン・ソシエテ・アノニム ヘテロオリゴマーマイコバクテリア抗原の融合物
WO2016131945A1 (en) 2015-02-20 2016-08-25 Transgene Sa Combination product with autophagy modulator
FR3042121A1 (fr) 2015-10-08 2017-04-14 Jean-Marc Limacher Composition anti-tumorale
US20190134190A1 (en) 2016-05-04 2019-05-09 Transgene Sa Combination therapy with cpg tlr9 ligand
KR102634221B1 (ko) * 2016-07-12 2024-02-07 에뮬레이트, 인크. 마이크로유체 장치에서의 버블 제거
EP3522920A2 (en) 2016-10-10 2019-08-14 Transgene SA Immunotherapeutic product and mdsc modulator combination therapy
CN111065406A (zh) 2017-06-21 2020-04-24 特兰斯吉恩股份有限公司 个性化疫苗
EP3842065A1 (en) 2019-12-23 2021-06-30 Transgene Process for designing a recombinant poxvirus for a therapeutic vaccine
WO2023213763A1 (en) 2022-05-02 2023-11-09 Transgene Poxvirus encoding a binding agent comprising an anti- pd-l1 sdab
WO2023213764A1 (en) 2022-05-02 2023-11-09 Transgene Fusion polypeptide comprising an anti-pd-l1 sdab and a member of the tnfsf

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2384845A1 (fr) * 1976-08-05 1978-10-20 Anvar Vaccin contre la myxomatose et nouvelle souche virale utilisee
JPS60202827A (ja) * 1984-03-28 1985-10-14 Chibaken 弱毒痘そうワクチン株
CA1341245C (en) * 1988-01-12 2001-06-05 F. Hoffmann-La Roche Ag Recombinant vaccinia virus mva
DE4405841C1 (de) * 1994-02-23 1995-01-05 Mayr Anton Prof Dr Med Vet Dr Multipotente Paramunitätsinducer auf der Basis von Kombinationen von Pockenviruskomponenten, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
US5616487A (en) * 1994-09-15 1997-04-01 Aastrom Biosciences, Inc. Stabilized retrovirus compositions
JPH11512609A (ja) * 1995-09-27 1999-11-02 アメリカ合衆国 クローン化されたヌクレオチド配列からの感染性ＲＳウイルス（ｒｅｓｐｉｒａｔｏｒｙ ｓｙｎｃｙｔｉａｌ ｖｉｒｕｓ）の生産
EP2112220A3 (en) * 1996-07-15 2010-01-06 The Government of the United States of America, as represented by The Department of Health and Human Services Production of attenuated respiratory syncytial virus vaccines from cloned nucleotide sequences
EE05680B1 (et) * 2000-11-23 2013-10-15 Bavarian Nordic A/S Muundatud vaktsiiniaviirus, selle valmistamine ja kasutamine, seda sisaldav farmatseutiline kompositsioon ning vaktsiin

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO343489B1 (no) * 2002-09-05 2019-03-25 Bavarian Nordic As Fremgangsmåte til amplifisering av en poxvirus under serumfrie betingelser.

Also Published As

Publication number Publication date
HK1066245A1 (en) 2005-03-18
CA2450206A1 (en) 2003-01-30
EP1412486B1 (en) 2007-11-28
BRPI0211276B1 (pt) 2018-12-04
DE60223812T2 (de) 2008-11-13
KR20040018474A (ko) 2004-03-03
NZ529914A (en) 2005-03-24
WO2003008533A3 (en) 2004-01-08
KR100908377B1 (ko) 2009-07-20
JP2011078424A (ja) 2011-04-21
HUP0400393A2 (hu) 2004-07-28
CN1533433A (zh) 2004-09-29
AU2002314201B2 (en) 2006-09-21
UA82466C2 (uk) 2008-04-25
EP1412486A2 (en) 2004-04-28
EA200400195A1 (ru) 2004-06-24
CA2450206C (en) 2012-08-21
MXPA04000326A (es) 2005-03-07
PL205926B1 (pl) 2010-06-30
JP2004535203A (ja) 2004-11-25
US6924137B2 (en) 2005-08-02
US20040234950A1 (en) 2004-11-25
JP5154632B2 (ja) 2013-02-27
IL158927A (en) 2009-09-01
WO2003008533A2 (en) 2003-01-30
BR0211276A (pt) 2004-08-03
DE60223812D1 (de) 2008-01-10
CN100513560C (zh) 2009-07-15
JP4700907B2 (ja) 2011-06-15
PL366897A1 (en) 2005-02-07
IL158927A0 (en) 2004-05-12
DK1412486T3 (da) 2008-03-10
EA006628B1 (ru) 2006-02-24
HUP0400393A3 (en) 2004-10-28
NO339056B1 (no) 2016-11-07

Similar Documents

Publication Publication Date Title
NO20035617D0 (no) Rörutvidelse
NL1022018A1 (nl) Belichtingswerkwijze.
NO20040158L (no) Fremgangsmåte til å amplifisere et Chordopoxvirus.
DE60221745D1 (de) Operationelle Verstärkerschaltung, Treiberschaltung und -Verfahren
DE60218781D1 (de) Operationelle Verstärkerschaltung, Treiberschaltung und -Verfahren
NO20042474L (no) Reguleringsventil-stromningsjusteringsanordning.
ATE502118T1 (de) Amplifizierungsverfahren
BR0204255B1 (pt) conjunto escavador de impacto.
DE60201856D1 (de) Klasse-D Verstärker
NO20040387L (no) Nedihullsfrigjoringskopling.
FR2849578B1 (fr) Piege a souris
NO20024780D0 (no) Konsentrisk brönnrör-jekk
DE60222443D1 (de) Vorverstärkungsschaltung
DZ3441A1 (fr) Nouvelles phenylpiperazines.
DE60225412D1 (de) Wanderfeldröhre
ES1048400Y (es) Bota-patin mejorada.
BR0103827B1 (pt) cola - pds.
PT1179650E (pt) Palco aperfeicoado
ES1049946Y (es) Caja-trampa antiorugas.
ES1050491Y (es) Chupete infantil.
BR8101236Y1 (pt) desensiladeira.
NO20040693L (no) Fermenteringsmetode.
ES1048140Y (es) Calcetin-zapato.
ES1049298Y (es) Embalaje-expositor.
ES1050980Y (es) Portalamparas.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees